Mariana C. Castells, MD, PhD is the director of the drug hypersensitivity and drug desensitization center and the mastocytosis center at Brigham & Women’s Hospital.
Elenestinib for ISM in Phase 2/3 HARBOR Trial with Mariana C. Castells, MD, PhD
Castells describes what’s missing from the current treatment landscape and the potential implications of elenestinib for indolent systemic mastocytosis.
Read More